Computer studies show MS fatigue surveys differ by person
By MS Buddy ·
Summarized from Multiple sclerosis (Houndmills, Basingstoke, England), Nov 2026 · PubMed · DOI. AI-generated summary. Not medical advice.
computer-simulated fatigue survey responses based on earlier MS research
Research by Jeremy Hobart, David Andrich and 2 colleagues at the University of Western Australia in Australia.
Do different MS fatigue surveys give the same results for each person?
Key Takeaway
Computer simulations found that MS fatigue surveys gave similar group averages but differed in individual scores and their ability to detect change.

What They Found
Six fatigue surveys produced similar average scores across the simulated group, but scores differed for some individuals. Surveys with more questions showed differences in fatigue scores for more individuals. Group averages suggested that all six surveys had the same ability to detect change. Looking at individuals showed that their ability to detect change differed. Surveys with fewer questions detected less change.
Who Should Care and Why
This study used computer simulations of fatigue survey data, rather than testing a treatment in people. It followed earlier research comparing six surveys completed by people with MS. The findings concern how studies measure fatigue in MS. Researchers choosing fatigue surveys may get different results depending on the number of questions. Group averages can hide differences in individual scores that matter for care.
Important Considerations
The researchers conducted four computer simulation studies; the abstract gives no number of human participants for this work. You cannot tell from group averages alone whether different fatigue surveys give similar results for each person. This study examined how fatigue is measured, not whether any treatment reduces it.
AI-generated summary — for informational purposes only, not medical advice
Read the original abstract
Published in Multiple sclerosis (Houndmills, Basingstoke, England) by et al.. Reproduced from the PubMed record.
Previously, we compared six better-developed fatigue patient-reported outcome measurement instruments administered concurrently to a multiple sclerosis sample. Examinations at the instrument level (items) and group level (sample mean fatigue severity scores) implied that all six instruments measured essentially the same variable. However, these same six instruments generated significantly different fatigue severity scores for up to 38% of individuals, implying that they frequently measured different fatigue-related variables. We explored the reproducibility, causes and extrapolation of those seemingly contradictory findings, using patient-reported outcome measures data simulation studies to enable examinations under controlled conditions that cannot be achieved easily by clinical studies. Four simulation studies were conducted to determine whether our clinical findings were reproducible (Study 1), explainable (Study 2), and extendable to measurement of change (Studies 3 and 4). Specifically, Study 1 replicated the conditions of our clinical study, reported in Part 1, to determine whether the findings were reproduced. Study 2 examined how patient-reported outcome measures instrument item number affected the group-level and individual-level equivalence of fatigue scores. Study 3 compared the ability of the six instruments used in our clinical study to detect change. Study 4 examined how item number influences the magnitude and significance of change measured at the group and individual levels. Study 1 reproduced our clinical observations. The six fatigue patient-reported outcome measure instruments produced equivalent mean fatigue severity scores for the sample, but at the same time variable proportions of individuals with significantly different fatigue severity scores. Study 2 showed that patient-reported outcome measure instruments with more items had more individuals with significantly different fatigue severity scores. Study 3 showed that these findings extended to measuring change. That is, group-level analyses implied that the six instruments had the same ability to detect change, whereas individual-level analyses showed that the six instruments had different abilities to detect change. Study 4 showed that instruments with more items detected more people with significant changes. When comparing patient-reported outcome measure instruments, group-level comparisons alone can be misleading because they can hide statistically significant and clinically meaningful differences between individuals' scores. The extent of these individual-level differences in scores is determined by the patient-reported outcome measure instrument's item number. Importantly for clinical trials, patient-reported outcome measure instruments with fewer items detect less change. These differences are only detectable using modern psychometric methods. Trialists should consider item numbers when selecting patient-reported outcome measure instruments; routinely examine individual differences; and use modern psychometric methods. These findings have significant implications for trial design and analyses.
Categories
Explore more research
Related MS research

11/17/2026
A review suggests MS fatigue may reflect extra effort to control movement and incomplete recovery af
Read More
11/17/2026
A review found exercise, therapy focused on thoughts and behavior, and self-management programs show
Read More
11/17/2026
Donated MS brain tissue showed damage in a vision hub. Mouse findings linked local immune cell activ
Read More
1/1/2026
A study of 318 people with MS linked lower thinking test scores to more sexual difficulties, with th
Read More
11/14/2026
In a review of records for 173 people taking Mavenclad for MS, most had no relapses over two years.
Read More
11/14/2026
In a study of people with MS, those with greater disability reported more voice problems and vocal f
Read MoreNot all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.
